{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T15:33:15Z","timestamp":1782487995215,"version":"3.54.5"},"reference-count":33,"publisher":"Bentham Science Publishers Ltd.","issue":"6","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDD"],"published-print":{"date-parts":[[2022,7]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Colorectal cancer (CRC) is the third most common cancer in the world. 5-\nFluorouracil (5-FU) is a conventional and most effective drug used in the clinic for the treatment of\nCRC. However, the clinical use of 5-FU is limited due to the acquired resistance and systemic\ntoxicity, such as hepatotoxicity and gastrointestinal toxicity.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>Recent advances in nanomedicine are being exploited to develop nanoparticle platforms\nto overcome resistance and therapeutic delivery of active molecules. Here, we developed 5-FU\nloaded sulfadiazine-poly(lactide-co-glycolide) nanoparticles (SUL-PLGA NPs) to be applied in the\ncolorectal cancer model.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>We assessed the in vivo efficacy of the SUL-PLGA NPs to enhance the antitumor effect\nof 5-FU.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>In vivo treatment with 5-FU-SUL-PLGA NPs significantly reduced tumor growth in a\ncolon cancer xenograft model compared to free 5-FU and 5-FU loaded non-targeted NPs. Treatment\nwith 5-FU-SUL-PLGA NPs also increased blood vessel diameters within tumors, which\ncould act in conjunction to enhance antitumor efficacy. In addition, 5-FU-SUL-PLGA NPs significantly\nreduced liver mass and lung mass, which are the most common metastasis sites of CRC, and\ndecreased liver hepatotoxicity compared to free 5-FU drug and 5-FU loaded non-targeted NPs.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Our findings suggest that the use of 5-FU-SUL-PLGA NPs is a promising strategy to\nenhance 5-FU efficacy against CRC.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1567201818666210729110127","type":"journal-article","created":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T04:34:51Z","timestamp":1627619691000},"page":"676-685","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Sulfonamide-Functionalized Polymeric Nanoparticles for Enhanced In\nVivo Colorectal Cancer Therapy"],"prefix":"10.2174","volume":"19","author":[{"given":"Rub\u00e9n D.","family":"Sinisterra","sequence":"first","affiliation":[{"name":"Chemistry Department, Institute of Exact Sciences, Universidade Federal de Minas Gerais, Av. Ant\u00f4nio Carlos, 6627, Pampulha, Belo Horizonte - MG, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro Pires Goulart","family":"Guimar\u00e3es","sequence":"additional","affiliation":[{"name":"Department of Physiology and Biophysics, Institute of Biological Sciences, Universidade Federal de Minas Gerais,\nAv. Ant\u00f4nio Carlos 6627, Pampulha, Belo Horizonte - MG, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celso Tarso Rodrigues","family":"Viana","sequence":"additional","affiliation":[{"name":"Department of Physiology and Biophysics, Institute of Biological Sciences, Universidade Federal de Minas Gerais,\nAv. Ant\u00f4nio Carlos 6627, Pampulha, Belo Horizonte - MG, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana","family":"Pereira","sequence":"additional","affiliation":[{"name":"Nursing Department, Universidade Federal de Alagoas,\nCampus Arapiraca. Av. Manoel Severino Barbosa - Bom Sucesso, Arapiraca - AL, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Savio Morato Lacerda","family":"Gontijo","sequence":"additional","affiliation":[{"name":"Department of Restorative Dentistry, Faculty of Dentistry, Universidade Federal de Minas Gerais, Av. Antonio Carlos, 6627, Pampulha, Belo Horizonte - MG, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula Peixoto","family":"Campos","sequence":"additional","affiliation":[{"name":"Department of General Pathology, Institute of Biological Sciences, Universidade Federal\nde Minas Gerais, Av. Ant\u00f4nio Carlos 6627, Pampulha, Belo Horizonte - MG, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia Passos","family":"Andrade","sequence":"additional","affiliation":[{"name":"Department of Physiology and Biophysics, Institute of Biological Sciences, Universidade Federal de Minas Gerais,\nAv. Ant\u00f4nio Carlos 6627, Pampulha, Belo Horizonte - MG, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robson A.S.","family":"Santos","sequence":"additional","affiliation":[{"name":"Department of Physiology and Biophysics, Institute of Biological Sciences, Universidade Federal de Minas Gerais,\nAv. Ant\u00f4nio Carlos 6627, Pampulha, Belo Horizonte - MG, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1136\/flgastro-2012-100141","volume":"3","author":"Riihim\u00e4ki M.","year":"2012","unstructured":"Riihim\u00e4ki M.; Thomsen H.; Sundquist K.; Hemminki K.; Colorectal cancer patients: what do they die of? Frontline Gastroenterol 2012,3(3),143-149","journal-title":"Frontline Gastroenterol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"29765","DOI":"10.1038\/srep29765","volume":"6","author":"Riihim\u00e4ki M.","year":"2016","unstructured":"Riihim\u00e4ki M.; Hemminki A.; Sundquist J.; Hemminki K.; Patterns of metastasis in colon and rectal cancer. Sci Rep 2016,6,29765-5","journal-title":"Sci Rep"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"900","DOI":"10.7150\/jca.14506","volume":"7","author":"He J.","year":"2016","unstructured":"He J.; Liang X.; Luo F.; Chen X.; Xu X.; Wang F.; Zhang Z.; P53 is involved in a three-dimensional architecture-mediated decrease in chemosensitivity in colon cancer. J Cancer 2016,7(8),900-909","journal-title":"J Cancer"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.7150\/jca.18171","volume":"8","author":"He J.","year":"2017","unstructured":"He J.; Pei L.; Jiang H.; Yang W.; Chen J.; Liang H.; Chemoresistance of colorectal cancer to 5-fluorouracil is associated with silencing of the BNIP3 gene through aberrant methylation. J Cancer 2017,8(7),1187-1196","journal-title":"J Cancer"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1007\/s00018-008-8557-5","volume":"66","author":"Wyatt M.D.","year":"2009","unstructured":"Wyatt M.D.; Wilson D.M.; Participation of DNA repair in the response to 5-fluorouracil. Cell Mol Life Sci 2009,66(5),788-799","journal-title":"Cell Mol Life Sci"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.canlet.2008.03.008","volume":"267","author":"Ooyama A.","year":"2008","unstructured":"Ooyama A.; Oka T.; Zhao H-Y.; Yamamoto M.; Akiyama S.; Fukushima M.; Anti-angiogenic effect of 5-Fluorouracil-based drugs against human colon cancer xenografts. Cancer Lett 2008,267(1),26-36","journal-title":"Cancer Lett"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"466","DOI":"10.7150\/ijbs.5.466","volume":"5","author":"El-Sayyad H.I.","year":"2009","unstructured":"El-Sayyad H.I.; Ismail M.F.; Shalaby F.M.; Abou-El-Magd R.F.; Gaur R.L.; Fernando A.; Raj M.H.; Ouhtit A.; Histopathological effects of cisplatin, doxorubicin and 5-flurouracil (5-FU) on the liver of male albino rats. Int J Biol Sci 2009,5(5),466-473","journal-title":"Int J Biol Sci"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.cyto.2012.10.003","volume":"61","author":"Soares P.M.G.","year":"2013","unstructured":"Soares P.M.G.; Mota J.M.S.C.; Souza E.P.; Justino P.F.C.; Franco A.X.; Cunha F.Q.; Ribeiro R.A.; Souza M.H.; Inflammatory intestinal damage induced by 5-fluorouracil requires IL-4. Cytokine 2013,61(1),46-49","journal-title":"Cytokine"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.3390\/molecules13081551","volume":"13","author":"Zhang N.","year":"2008","unstructured":"Zhang N.; Yin Y.; Xu S-J.; Chen W-S.; 5-Fluorouracil: mechanisms of resistance and reversal strategies. Molecules 2008,13(8),1551-1569","journal-title":"Molecules"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.3390\/polym3031377","volume":"3","author":"Makadia H.K.","year":"2011","unstructured":"Makadia H.K.; Siegel S.J.; Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers (Basel) 2011,3(3),1377-1397","journal-title":"Polymers (Basel)"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.colsurfb.2015.09.005","volume":"136","author":"Guimar\u00e3es P.P.G.","year":"2015","unstructured":"Guimar\u00e3es P.P.G.; Oliveira M.F.; Gomes A.D.M.; Gontijo S.M.L.; Cort\u00e9s M.E.; Campos P.P.; Viana C.T.; Andrade S.P.; Sinisterra R.D.; PLGA nanofibers improves the antitumoral effect of daunorubicin. Colloids Surf B Biointerfaces 2015,136,248-255","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/nrc.2016.108","volume":"17","author":"Shi J.","year":"2017","unstructured":"Shi J.; Kantoff P.W.; Wooster R.; Farokhzad O.C.; Cancer nanomedicine: progress, challenges and opportunities. Nat Rev Cancer 2017,17(1),20-37","journal-title":"Nat Rev Cancer"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"15101","DOI":"10.1073\/pnas.1213353109","volume":"109","author":"Stylianopoulos T.","year":"2012","unstructured":"Stylianopoulos T.; Martin J.D.; Chauhan V.P.; Jain S.R.; Diop-Frimpong B.; Bardeesy N.; Smith B.L.; Ferrone C.R.; Hornicek F.J.; Boucher Y.; Munn L.L.; Jain R.K.; Causes, consequences, and remedies for growth-induced solid stress in murine and human tumors. Proc Natl Acad Sci USA 2012,109(38),15101-15108","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/nrclinonc.2010.139","volume":"7","author":"Jain R.K.","year":"2010","unstructured":"Jain R.K.; Stylianopoulos T.; Delivering nanomedicine to solid tumors. Nat Rev Clin Oncol 2010,7(11),653-664","journal-title":"Nat Rev Clin Oncol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"19048","DOI":"10.1073\/pnas.1315336110","volume":"110","author":"Tong R.","year":"2013","unstructured":"Tong R.; Chiang H.H.; Kohane D.S.; Photoswitchable nanoparticles for in vivo cancer chemotherapy. Proc Natl Acad Sci USA 2013,110(47),19048-19053","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1021\/nn305011p","volume":"7","author":"Sano K.","year":"2013","unstructured":"Sano K.; Nakajima T.; Choyke P.L.; Kobayashi H.; Markedly enhanced permeability and retention effects induced by photo-immunotherapy of tumors. ACS Nano 2013,7(1),717-724","journal-title":"ACS Nano"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.jconrel.2010.01.002","volume":"142","author":"Maeda H.","year":"2010","unstructured":"Maeda H.; Nitroglycerin enhances vascular blood flow and drug delivery in hypoxic tumor tissues: analogy between angina pectoris and solid tumors and enhancement of the EPR effect. J Control Release 2010,142(3),296-298","journal-title":"J Control Release"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1111\/j.1349-7006.2011.02178.x","volume":"103","author":"Fang J.","year":"2012","unstructured":"Fang J.; Qin H.; Nakamura H.; Tsukigawa K.; Shin T.; Maeda H.; Carbon monoxide, generated by heme oxygenase-1, mediates the enhanced permeability and retention effect in solid tumors. Cancer Sci 2012,103(3),535-541","journal-title":"Cancer Sci"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.1073\/pnas.1018892108","volume":"108","author":"Diop-Frimpong B.","year":"2011","unstructured":"Diop-Frimpong B.; Chauhan V.P.; Krane S.; Boucher Y.; Jain R.K.; Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors. Proc Natl Acad Sci USA 2011,108(7),2909-2914","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1002\/adfm.200601188","volume":"17","author":"Kang H.C.","year":"2007","unstructured":"Kang H.C.; Bae Y.H.;  Adv Funct Mater 2007,17(8),1263-1272","journal-title":"Adv Funct Mater"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0168-3659(02)00345-0","volume":"87","author":"Na K.","year":"2003","unstructured":"Na K.; Lee E.S.; Bae Y.H.; Adriamycin loaded pullulan acetate\/sulfonamide conjugate nanoparticles responding to tumor pH: pH-dependent cell interaction, internalization and cytotoxicity in vitro. J Control Release 2003,87(1-3),3-13","journal-title":"J Control Release"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s11095-007-9480-4","volume":"25","author":"Sethuraman V.A.","year":"2008","unstructured":"Sethuraman V.A.; Lee M.C.; Bae Y.H.; A biodegradable pH-sensitive micelle system for targeting acidic solid tumors. Pharm Res 2008,25(3),657-666","journal-title":"Pharm Res"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1517\/13543776.10.11.1725","volume":"10","author":"Owa T","year":"2000","unstructured":"Owa T; Nagasu T;  Expert opinion on therapeutic patents 2000,10(11),1725-1740","journal-title":"Expert opinion on therapeutic patents"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"3789","DOI":"10.1021\/jm9902638","volume":"42","author":"Owa T.","year":"1999","unstructured":"Owa T.; Yoshino H.; Okauchi T.; Yoshimatsu K.; Ozawa Y.; Sugi N.H.; Nagasu T.; Koyanagi N.; Kitoh K.; Discovery of novel antitumor sulfonamides targeting G1 phase of the cell cycle. J Med Chem 1999,42(19),3789-3799","journal-title":"J Med Chem"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"925","DOI":"10.2174\/0929867033457647","volume":"10","author":"Scozzafava A.","year":"2003","unstructured":"Scozzafava A.; Owa T.; Mastrolorenzo A.; Supuran C.T.; Anticancer and antiviral sulfonamides. Curr Med Chem 2003,10(11),925-953","journal-title":"Curr Med Chem"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"5817","DOI":"10.1016\/j.ejmech.2011.09.039","volume":"46","author":"Kamal A.","year":"2011","unstructured":"Kamal A.; Dastagiri D.; Ramaiah M.J.; Reddy J.S.; Bharathi E.V.; Reddy M.K.; Sagar M.V.; Reddy T.L.; Pushpavalli S.N.; Pal-Bhadra M.; Synthesis and apoptosis inducing ability of new anilino substituted pyrimidine sulfonamides as potential anticancer agents. Eur J Med Chem 2011,46(12),5817-5824","journal-title":"Eur J Med Chem"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"879","DOI":"10.3390\/molecules20010879","volume":"20","author":"Guimar\u00e3es P.P.G.","year":"2015","unstructured":"Guimar\u00e3es P.P.G.; Oliveira S.R.; de Castro Rodrigues G.; Gontijo S.M.; Lula I.S.; Cort\u00e9s M.E.; Denadai \u00c2.M.; Sinisterra R.D.; Development of sulfadiazine-decorated PLGA nanoparticles loaded with 5-fluorouracil and cell viability. Molecules 2015,20(1),879-899","journal-title":"Molecules"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.mvr.2012.12.002","volume":"86","author":"Viana C.T.R.","year":"2013","unstructured":"Viana C.T.R.; Campos P.P.; Carvalho L.A.; Cenedezi J.M.; Lavall L.; Lopes M.T.P.; Ferreira M.A.; Andrade S.P.; Distinct types of tumors exhibit differential grade of inflammation and angiogenesis in mice. Microvasc Res 2013,86,44-51","journal-title":"Microvasc Res"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1128\/AAC.01499-13","volume":"58","author":"Kato K.C.","year":"2014","unstructured":"Kato K.C.; Morais-Teixeira E.; Reis P.G.; Silva-Barcellos N.M.; Sala\u00fcn P.; Campos P.P.; Dias Corr\u00eaa-Junior J.; Rabello A.; Demicheli C.; Fr\u00e9zard F.; Hepatotoxicity of pentavalent antimonial drug: possible role of residual Sb(III) and protective effect of ascorbic acid. Antimicrob Agents Chemother 2014,58(1),481-488","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/nrc.2016.127","volume":"16","author":"Villanueva M.T.","year":"2016","unstructured":"Villanueva M.T.; Angiogenesis: going with the flow. Nat Rev Cancer 2016,16(12),751","journal-title":"Nat Rev Cancer"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"12320","DOI":"10.1002\/anie.201403036","volume":"53","author":"Sun T.","year":"2014","unstructured":"Sun T.; Zhang Y.S.; Pang B.; Hyun D.C.; Yang M.; Xia Y.; Engineered nanoparticles for drug delivery in cancer therapy. Angew Chem Int Ed Engl 2014,53(46),12320-12364","journal-title":"Angew Chem Int Ed Engl"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nrc1074","volume":"3","author":"Longley D.B.","year":"2003","unstructured":"Longley D.B.; Harkin D.P.; Johnston P.G.; 5-fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer 2003,3(5),330-338","journal-title":"Nat Rev Cancer"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"Hanahan D.","year":"2011","unstructured":"Hanahan D.; Weinberg R.A.; Hallmarks of cancer: the next generation. Cell 2011,144(5),646-674","journal-title":"Cell"}],"container-title":["Current Drug Delivery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1567201818666210729110127","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/195121\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1567201818666210729110127","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T10:52:11Z","timestamp":1671274331000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/195121\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1567201818666210729110127","relation":{},"ISSN":["1567-2018"],"issn-type":[{"value":"1567-2018","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-01-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-15","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-09","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}